Article Sidebar

PDF (Tiếng Việt)
Published: 2023-06-20
Abstract Views: 615
Views PDF (Tiếng Việt): 480
DOI: https://doi.org/10.52852/tcncyh.v167i6.1667
Issue
Vol. 167 No. 6 (2023)
Section
Các bài báo
How to Cite
Công, M. T., Huyền, T. T., Lê, N. T., Ngọc, L. T. K., & Ly, Đào K. (2023). 39. Bronchiolitis obliterans as a long-term sequela of mycoplasma pneumoniae-induced-stevens johnson: A case report. Journal of Medical Research, 167(6), 356-363. https://doi.org/10.52852/tcncyh.v167i6.1667

39. Bronchiolitis obliterans as a long-term sequela of mycoplasma pneumoniae-induced-stevens johnson: A case report

Mai Thanh Cong, Thuc Thanh Huyen, Nguyen Thi Le, Le Thi Kim Ngoc, Dao Khanh Ly

Main Article Content

Abstract

Steven-Johnson syndrome (SJS) is an immune-mediated hypersensitivity reaction, mainly related to medications and infections. It is characterized by blisters and extensive necrosis of the skin and mucous membranes, acute and usually self-limiting. Bronchiolitis Obliterans (BO) is a rare respiratory complication of SJS which occurs after the acute phase. We report a case of a 32-month-old boy diagnosed with SJS due to Mycoplasma pneumoniae, presenting with fever, cough, blister, oral mucosal ulcer and conjunctivitis, positive Mycoplasma pneumoniae test (IgM > 1352 U/mL). Skin and mucosal  lesions improved after 2 weeks, but after 5 weeks, he  developped wheezing and dyspnea. HRCT showed mosaic pattern, bronchial wall thichkening and air trapping. BO is a late respiratory complication of SJS. Long-term monitoring of respiratory manifestations in SJS patients is essential to have prompt interventions, avoiding more serious lung damage.

Article Details

Keywords

Bronchiolitis obliterans, Stevens Johnson syndrome, Mycoplasma pneumoniae

References

1. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol. 1993; 129(1): 92-96.
2. Hsu DY, Brieva J, Silverberg NB, Paller AS, Silverberg JI. Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States. J Am Acad Dermatol. 2017; 76(5): 811-817.e4. doi:10.1016/j.jaad.2016.12.024.
3. Hsu DY, Brieva J, Silverberg NB, Silverberg JI. Morbidity and Mortality of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in United States Adults. J Invest Dermatol. 2016; 136(7): 1387-1397. doi:10.1016/j.jid.2016.03.023.
4. Wetter DA, Camilleri MJ. Clinical, etiologic, and histopathologic features of Stevens-Johnson syndrome during an 8-year period at Mayo Clinic. Mayo Clin Proc. 2010; 85(2): 131-138. doi:10.4065/mcp.2009.0379.
5. Edwards C, Penny M, Newman J. Mycoplasma pneumonia, Stevens-Johnson syndrome, and chronic obliterative bronchitis. Thorax. 1983; 38(11): 867-869.
6. Chiu CY, Wong KS, Huang YC, Lin TY. Bronchiolitis obliterans in children: clinical presentation, therapy and long-term follow-up. J Paediatr Child Health. 2008; 44(3): 129-133. doi:10.1111/j.1440-1754.2007.01209.x.
7. Krishna R, Anjum F, Oliver TI. Bronchiolitis Obliterans. In: StatPearls. StatPearls Publishing; 2020. Accessed November 4, 2020. http://www.ncbi.nlm.nih.gov/books/NBK441865/.
8. Levi N, Bastuji-Garin S, Mockenhaupt M, et al. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis. Pediatrics. 2009; 123(2): e297-304. doi:10.1542/peds.2008-1923.
9. Kavaliunaite E, Aurora P. Diagnosing and managing bronchiolitis obliterans in children. Expert Rev Respir Med. 2019; 13(5): 481-488. doi:10.1080/17476348.2019.1586537.
10. Champs N da S, Lasmar LMLBF, Camargos PAM, Marguet C, Fischer GB, Mocelin HT. Post-infectious bronchiolitis obliterans in children. J Pediatr (Rio J). 2011; 87: 187-198. doi:10.1590/S0021-75572011000300003.
11. Eber CD, Stark P, Bertozzi P. Bronchiolitis obliterans on high-resolution CT: a pattern of mosaic oligemia. J Comput Assist Tomogr. 1993; 17(6): 853-856. doi:10.1097/00004728-199311000-00003.
12. Carpenter LM, Weinman JP, Aleksanyan Y, Mizoue AK, Deterding RR, Liptzin DR. Stevens-Johnson Syndrome in Children: Consider Monitoring for Bronchiolitis Obliterans. J Pediatr. 2021; 236: 307-311. doi:10.1016/j.jpeds.2021.05.036.
13. Seccombe EL, Ardern-Jones M, Walker W, et al. Bronchiolitis obliterans as a long-term sequela of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Clin Exp Dermatol. 2019; 44(8): 897-902. doi:10.1111/ced.13969.
14. Lebargy F, Wolkenstein P, Gisselbrecht M, et al. Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study. Intensive Care Med. 1997; 23(12): 1237-1244. doi:10.1007/s001340050492.
15. Rapidly Progressive Bronchiolitis Obliterans Associated with Stevens-Johnson Syndrome - ScienceDirect. Accessed March 17, 2023. https://www.sciencedirect.com/science/article/abs/pii/S0012369216412699.
16. Rosewich M, Zissler UM, Kheiri T, et al. Airway inflammation in children and adolescents with bronchiolitis obliterans. Cytokine. 2015; 73(1): 156-162. doi:10.1016/j.cyto.2014.10.026.
17. Jerkic SP, Brinkmann F, Calder A, et al. Postinfectious Bronchiolitis Obliterans in Children: Diagnostic Workup and Therapeutic Options: A Workshop Report. Can Respir J. 2020; 2020:e5852827. doi:10.1155/2020/5852827.
18. Verleden GM, Vanaudenaerde BM, Dupont LJ, Van Raemdonck DE. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med. 2006; 174(5): 566-570. doi:10.1164/rccm.200601-071OC.
19. Kim CK, Kim SW, Kim JS, et al. Bronchiolitis Obliterans in the 1990s in Korea and the United States. Chest. 2001; 120(4): 1101-1106. doi:10.1378/chest.120.4.1101.